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Introduction
Malignant pleural mesothelioma (MPM) is an aggressive 
tumor of the mesothelial lining of the chest and is most 
commonly associated with an occupational exposure to 
asbestos (1). In most cases, MPM shows a diffuse growth 
pattern and spreads widely across the pleural surface (2). 
However, sporadic cases of localized MPM with a bulky, 
circumscribed appearance have been initially described over 
40 years ago (3). While both, localized and diffuse MPM, 
display identical histological, immunohistochemical and 
molecular characteristics, localized MPM mostly show a 
less aggressive clinical course and the role of chemotherapy 
after localized surgical resection remains controversial (4-7). 
In order to differentiate between a localized MPM and 
the rare variant of a diffuse MPM with a dominant, 
circumscribed mass, a complete examination of the pleural 
cavity is required (5). 
Computed tomography (CT) in general is the standard 
of reference for primary assessment of tumor extend. For 
tumor staging 18F-fluorodeoxyglucose (18F-FDG) positron 
emission computed tomography (PET-CT) is used. 
However, there are different studies showing that magnetic 
resonance tomography (MRI) goes beyond CT concerning 
the depiction of diaphragmatic and chest wall infiltration.
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a disseminated pleural spread, corresponding to a diffuse pleural mesothelioma. The patient made an 
uneventful recovery and the radiological follow-up 1 year after surgery showed no signs of relapse. This case 
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Here, we report the rare case of a diffuse MPM with 
radiologically localized appearance and transdiaphragmatic 
infiltration. The atypical presentation featuring a solitary 
tumor bulk and the subsequent histological confirmation 
of a disseminated disease add to the educational value of 
this case. In addition, the surgical planning was primarily 
performed according to the findings of the preoperative 
MRI. The role of MRI for preoperative planning has 
not been previously described and clinical evidence is 
therefore poor. For the review of clinical records and 
the publication of this case, an informed consent was 
obtained from the patient. A timeline of each diagnostic or 
therapeutic intervention is depicted in Figure 1. We present 
the following article/case in accordance with the CARE 
guideline checklist (available at http://dx.doi.org/10.21037/
ccts-20-41).
Case presentation
A 58-year-old female patient from east Asia presented with a 
recent onset of postprandial gastric discomfort, night sweats 
and weight loss. While both gastroscopy and colonoscopy 
showed not pathological findings, a CT revealed a solitary, 
partly solid and partly cystic pleural mass, measuring 9.4 cm 
× 5.8 cm. The tumor was located on the left diaphragm 
with transdiaphragmal infiltration and slight displacement 
of the stomach, the spleen and the liver (Figure 2). No 
pleural or peritoneal effusion was present. Upon CT-guided 
transthoracic biopsy, a MPM with epithelioid differentiation 
was diagnosed. Immunohistochemistry showed a positivity 
for CK5/6, CK7 and WT1. In the immunostaining for 
BAP-1 no retained expression was identified. The patient 
had no suggestive occupational history of exposure to 
asbestos. Following further staging by PET-CT, no 
other pleural or abdominal lesions and no mediastinal 
lymphadenopathy were identified and a clinical T4 N0 M0 
status was defined. The mesothelioma showed a 18F-FDG 
accumulation with maximum standardized uptake value 
(SUVmax) of 15.2. The calculated total tumor volume was 
estimated at 250 mL. Due to the localized finding without 
signs of diffuse pleural dissemination or other distant 
manifestations, a direct resection was recommended in our 
interdisciplinary tumor board. Pre-operative spirometry 
showed sufficient functional reserve [FEV1: 1.86L (84% of 
set)] and the perfusion of the diseased left lung (V/Q-scan) 
was only moderately reduced at 37%. For preoperative 
planning a MRI of the chest was performed, showing the 
transdiaphragmatic growth and infiltration into chest wall 
(Figures 2,3,4). The tumor showed a moderate contrast-
uptake but a high signal on diffusion-weighted image, which 
is typical for epitheleoid mesothelioma. Furthermore, the 
MR showed an infiltration into the fascia endothoracica of 
the chest wall (Figure 4).
The patient underwent an extended pleurectomy 
and decortication with resection of pericardium and 
diaphragm, followed by a systematic lymphadenectomy 
of the mediastinal lymph nodes (Supplementary file). The 
pericardium was reconstructed with an acellular biological 
patch. After resection of the diaphragm encompassing 
the bulky tumor, the peritoneal cavity was opened and 
Timeline and duration of the treatment:
Computed tomography: 







cT4 cN0 cM0 status
Spirometry, V/Q scan: 
sufficient functional 
reserve to tolerate EPD
Interdisciplinary tumor board: 
primary resection recommended
Chest MRI: 







Interdisciplinary tumor board: 
patient refrains from recommended 
adjuvant chemotherapy
1y Follow-up:
no signs of recurrence
Months:   0 21 12
Histological analysis: 
pT4 pN0 status
Figure 1 Timeline and duration of the diagnostic and therapeutic interventions, including the follow-up period up to date. CT, computed 
tomography; MRI, magnetic resonance tomography; PET, positron emission tomography; V/Q-scan, ventilation-perfusion scan.
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inspected. Apart from minor adhesions of the tumor bulk 
to the greater omentum, no infiltration into the visceral 
organs was seen macroscopically. The adhesive region 
of the omentum was resected and the diaphragm was 
reconstructed with a Gore-Tex® Dualmesh® biomaterial 
patch (W.L. Gore & Associates Inc., Flagstaff, AZ, USA). 
Single wedge-resections were necessary in two sites where 
an infiltration into the lung parenchyma was suspected. 
While the histological analysis of the partially resected 
greater omentum confirmed no malignant process, 
infiltrations of the epithelioid pleural mesothelioma were 
verified in the specimens of both visceral- and parietal 
pleura, pericardium and lung parenchyma, corresponding to 
a pathological T4 N0 M0 status.
The patient was discharged after an uneventful 
recovery on the 11 th postoperative day. Within the 
intended multimodality treatment approach, an adjuvant 
chemotherapy with platinum and pemetrexed was planned. 
However, the patient wished to refrain from chemotherapy. 
To date, regular clinical and radiological follow-up 1 year 
after surgery shows no signs of relapse. 
Comment
Our case demonstrates a diffuse MPM with a dominant 
mass on the left hemidiaphragm and transdiaphragmatic 
infiltration. The radiological findings were at first not 





Figure 2 Pre-operative scans in coronal plane. (A) CT, (B) T1-weighted MRI and (C) 18F-FDG-PET/CT demonstrating focus of left-sided 
MPM with transdiaphragmatic infiltration and slight displacement of the stomach, the spleen and the liver. (D) Intraoperative view of the 
resected bulky tumor (9.4 cm × 5.8 cm).
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lymphoma, gastrointestinal stromal tumor or mesenchymal 
tumors. After histological confirmation of an epithelioid 
pleural malignancy, a localized MPM was suspected and 
the patient was therefore referred directly for operative 
resection, without neoadjuvant chemotherapy, our usual 
concept of MPM treatment. The intraoperative examination 
of the complete pleural cavity unfortunately revealed 
additional nodular lesions on the pericardium, the parietal 
and the visceral pleura, corresponding to a disseminated 
disease. Consequently, an adjuvant chemotherapy with 
platinum and pemetrexed was recommended by our 
interdisciplinary tumor board. 
L o c a l i z e d  M P M  a r e  a s s u m e d  t o  a c c o u n t  f o r 
approximately 0.5% of all MPM cases (5). Histologically 
and immunohistochemical ly,  local ized MPM are 
indistinguishable from diffuse MPM (4,5). In a recent study 
by Hung et al., localized MPM was furthermore found to 
harbor similar genomic alterations such as BAP1 mutations, 
deletions in CDKN2A and NF2, TRAF7-mutations and 
genomic near-haploidization (5). Contrary to diffuse MPM, 
the association with asbestos exposure and male sex is not 
as strong and the clinical course is often less aggressive (4). 
In the largest case series to date by Allen et al., 48% of all 
patients with localized MPM undergoing isolated surgical 
resection were free from recurrence after a mean follow-
up of 4.8 years (4). Hence, an aggressive treatment and 
surgical excision is recommended. However, the role of 
chemotherapy has yet to be assessed in these patients (5-7). 
In contrast, international guidelines are established for 
the initial treatment of diffuse MPM and a multimodality 
concept including (neo)- or adjuvant chemotherapy with 
platinum and anti-folate doublet, followed by macroscopic 
complete resection has been shown to extend the overall- 
and disease-free survival (8-13).
Figure 3 Comparison of contrast-enhanced computed tomography and T1-weighted magnetic resonance imaging in respect to soft tissue 
resolution and identification of chest wall infiltration. (A) Axial view of the left-sided MPM on contrast enhanced computed tomography of 
the chest; (B) T1-weighted magnetic resonance imaging with better soft tissue contrast and therefore providing more details on chest wall 
and diaphragm invasion.
BA
Figure 4 The different roles of T1-weighted and diffusion-weighted magnetic resonance imaging in MPM. (A) Axial T1-weighted MRI 
showing soft tissue infiltration of the MPM; (B) diffusion-weighted MR imaging (DWI) demonstrating excellent differentiation of malignant 
pleural disease (white lighted area) from benign pleural alterations. 
BA
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Regarding imaging assessment, chest X-ray is usually the 
first-line diagnostic approach of MPM showing suspicious 
unilateral pleural effusion, unilateral pleural thickening with 
or without thickening pleural fissures, multiple masses with 
peripheral distribution or loss of volume in the involved 
hemithorax (14). Contrast enhanced CT of the chest 
represents the gold standard to evaluate MPM associated 
features like circumferential pleural thickening (pleural 
rind), thickened mediastinal pleura, nodular or irregular 
pleural thickening, infiltration of chest wall, diaphragm, 
mediastinum or pericardium and lymph nodes in extra 
pleural fat tissue (15). Although MRI is not routinely 
performed in patients with MPM, it has excellent soft tissue 
contrast and is therefore superior to CT for assessing chest 
wall and diaphragm invasion and revealing endothoracic 
fascia involvement (Figure 3) (16). Furthermore, recent 
studies have shown promising benefits of diffusion-
weighted MR imaging (DWI) to differentiate malignant 
pleural disease from benign pleural alterations (Figure 4) (17) 
and delayed phase enhancement MRI and early contrast-
enhancement MRI are on the verge of significantly improve 
the accuracy of early diagnosis as well as staging and 
therapy response assessment of MPM (18,19). Meanwhile, 
18F-FDG-PET/CT surpasses CT and MRI in N and M 
staging of MPM (but not for T-staging) and is beneficial for 
evaluating treatment response and detection of recurrent 
disease (20).
While diffuse MPM most commonly presents as a uniform 
thickening of the pleura, rare cases featuring a circumscribed, 
bulky lesion may mimic a localized MPM (4,5). Our case 
report displays that their distinction may be difficult based 
on the preoperative radiological or bioptic findings. The 
case therefore highlights the importance of a meticulous 
intraoperative examination of the pleural cavity in 
patients where a localized MPM is suspected. The direct 
comparability between radiological findings from PET-
CT and MRI with intraoperative, macroscopic findings 
and histological, microscopic results substantiate this 
conclusion in our case. The circumstance that localized 
pleural mesothelioma forms a rare disease makes it difficult 
to confirm our findings with other cases. The limitation of 
this case report are therefore its limited external validity and 
generalizability. 
Conclusions
This case of a localized variant of epithelioid mesothelioma 
with transdiaphragmatic growth highlights the importance 
of MRI for a thorough preoperative assessment and of a 
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Dr. Hon Chi Suen (Hong Kong, China): The MRI showed infiltration of the endothoracic fascia that CT and PET scan did 
not show. Did this finding alter the surgical approach and if it did, how?
Dr. Thomas Frauenfelder (Zurich, Switzerland): Dr. Suen raises an important question. In patients with diffuse malignant 
pleural mesothelioma scheduled for macroscopic complete resection (either by extended pleurectomy and decortication 
or extrapleural pneumonectomy) after induction chemotherapy, the detection of multilevel chest wall infiltration is 
most commonly a reason to refrain from radical surgery. In patients where multilevel chest wall infiltration is identified 
intraoperatively by repeated biopsies and frozen section of suspicious lesions, a parietal pleurectomy without decortication 
of the visceral pleura is in our opinion a reasonable alternative. We experienced that this approach reduces the duration of 
postoperative air-leak, while still enabling a de-bulking. In patients where a multilevel chest wall infiltration is preoperatively 
seen in the MRI, the further treatment plan should be re-discussed at an interdisciplinary tumor board with attending experts 
in medical oncology, thoracic surgery and radiation oncology.
In our case, the infiltration into the endothoracic fascia was localized to the single tumor bulk and was not considered to be 
multifocal. We therefore proceeded with the intended resection. However, in patients with unifocal chest wall infiltration we 
intraoperatively mark the affected area with metal clips in order to facilitate the targeting of a potential adjuvant stereotactic 
body radiation therapy.
Dr. Suen: The localized main bulk of tumor was transdiaphragmatic. Would you have performed a laparoscopy first to see if 
there was diffuse peritoneal mesothelioma as well?
Dr. Frauenfelder: This is an excellent remark. Due to the localized appearance of the mesothelioma without radiological 
signs of further pleural, abdominal or mediastinal lesions, the patient was directly referred for resection of the tumor. With 
respect to the disseminated disease that was detected intraoperatively, a preceding laparoscopy could have been considered in 
hindsight.
Dr. Suen: Since initially, it was thought that the tumor was localized to the diaphragm and the plan was to perform a local 
excision, what was the incision? When it was found that there was actually diffuse malignant pleural mesothelioma, how 
was the incision modified to accomplish pleurectomy and decortication of the entire left chest?
Dr. Frauenfelder: Dr. Suen addresses a crucial factor of our surgical approach for malignant pleural mesothelioma. For 
extended pleurectomy and decortication, as well as for extrapleural pneumonectomy we perform an extended lateral 
thoracotomy and enter the 6th intercostal space. In all cases, the costal arch is ventrally excised for an improved exposure 
of the situs. This maneuver considerably facilitates the dissection of the costophrenic sinus and resection of the diaphragm. 
Therefore, no further utility thoracotomy is required. 
Since in our case, a local resection and reconstruction of the diaphragm had already been planned, the abovementioned 
incision was performed in the first place and was well suitable for the subsequent pleurectomy and decortication.
